No treatment or vaccine against Ebola

Extremely low risk

This is the first time a person infected with Ebola virus is on American soil, but American authorities say they are confident and able to protect the public from the risk of transmission. "Doctors, nurses and staff of the University Hospital Emory can treat both patients safely and effectively. We are honored to have the privilege of treating these patients who contracted Ebola participating in a mission humanitarian, "said the hospital in a statement.

It stated that Dr. Brantly and Nancy are the only two Writebol patients treated at their institution, "not because of the risk of contamination, but rather for reasons of protection of privacy, given the widespread interest in these patients, "he said hospital.

Ebola is a virulent pathogen that causes a mortality of 60-90% of patients. It is transmitted through direct contact with body fluids such as blood or sweat of patients with symptoms. "The risk (of contamination, Ed) is extremely low, because even if someone is infected in the United States or other developed countries, it is highly unlikely that the virus can spread the light of hospital capacity to isolate these patients, "said Dr. Anthony Fauci, director of the American Institute of Allergy and Infectious Diseases (NIAID).

Ebola infected American arrived in the United States

Ebola infected American arrived in the United States
The Point.fr - Published 08/03/2014 at 09:42 - Amended 08/03/2014 at 13:17
The arrival of Dr. Kent Brantly Saturday the United States is the first case, on American soil, a person suffering from Ebola.

One of two Americans infected with Ebola virus in Africa , where an epidemic is unprecedented, was evacuated by air ambulance and arrived Saturday in the United States , where it must be treated in a special unit of quarantine. This is the first time that a person with Ebola is on American soil. The private aircraft, a specially equipped Gulfstream carrying Dr. Kent Brantly, landed in the late morning on the Dobbins Air Force Base ( Georgia , southeast) near Atlanta, said in a statement Samaritan's Purse the charity, which employs both sick.

Visit our dossier: The best of the literary season

Look Zola heredity covers the whole range of possibilities: one is an alcoholic, tuberculosis, invert, from father to son, it's inevitable. And do not support me otherwise! We would imagine that as the child is born pure, devoid of a priori on the world. Error! Angelic bullshit! Idealism fool! Once laid, it is marked in the iron. We all calves whose skin reddens as metal.

Rogis born, I stayed. My relationship with sensuality, sex, suddenly seems so trivial, so readable. It's me, the vampire. These one-night stands, these crazes guzzler. My nights with cannibals Cecile great intoxication of triumphant body, blood that enjoys. It's the only pleasure I have power. The executioner is not entitled to feeling, if he falters. It should not be touched, ever! That's why I threw Aurora homeless. By loving, I lost my strength, I hypothéquais my neutrality; I ébréchais my ax. By loving, I became again human.

Check out an excerpt from the latest novel by Nicolas d'Estienne d'Orves

Nicolas d'Estienne d'Orves, devouring , Albin Michel , 320 pages, 20 euros. In bookstores August 20, 2014.

Check out an excerpt from the latest novel by Nicolas d'Estienne d'Orves:

I am not an arm of justice. For novels, I took on the role of executioner, I am master of high works. Readers need that. They feel better, strengthened this conviction. The suffering of others, it's reassuring. There are always worse off. In fact, I am needed, we have always been essential to the smooth running of the company. We are a pivot. Remove us was a strategic mistake. Since then, people crave. They need the carnage. See their passion for movies gory, horrific for new for the world's pain. See their morbid joy to behold cataclysms. See the hours they spend on the Internet looking for snuff movies , hand in pants, tidying themselves to wound?

Back literary: Nicolas d'Estienne d'Orves, praise the cannibalism

Back literary: Nicolas d'Estienne d'Orves, praise the cannibalism
The Point.fr - Published 08/03/2014 at 16:19 - Amended 08/03/2014 at 17:19
Every day, The Point.fr you discover the best of the literary season. Today, "devouring" of Nicolas d'Estienne d'Orves.

Back literary: Nicolas d'Estienne d'Orves, praise the cannibalism

Nicolas is a writer and lives in Paris . With his mother, because he never could write a line other than his childhood bedroom ... His favorite subject? Blood. Suffering, pain, sordid crimes more or less romanticized that sell like hotcakes and for which one makes hours in line at the book fair. The great success of the Cult of blood succeed Joys of evil , The Apology of suffering, pain ... Naked "Snapshots of massacres that collect necklaces of praise."

MetroPCS adds LG Optimus F6 to portfolio

DroidStars.com

MetroPCS has announced the addition of the LG Optimus F6 smartphone to their portfolio of devices available for buyers on their prepaid no-annual-contract service. The LG Optimus F6 will be able to access the T-Mobile 4G LTE network via a MetroPCS unlimited data, talk and text plan starting at just $40 per month. MetroPCS is offering the Optimus F6 for $199 through retail stores and online at their web site. The Optimus F6 has a 4.5-inch display, a 1.2GHz dual-core processer, a 5MP 1080p capable rear-facing camera, and comes with Android 4.1 installed. Hit the break to read the full press release for more details if you are interested in grabbing an Optimus F6 from MetroPCS.

Sharp announces Aquos Xx and Aquos Xx Mini

Another day, another Snapdragon 800-powered Android smartphone. Sharp announced their latest flagship offering for Japanese carrier Softbank, called the Aquos Xx, and it’s got specs to compete with any other phone on the market. You get the de facto standard flagship processor, a Snapdragon 800, 2 GB of RAM, a full 1080p, 5.5-inch screen, and a 16.3 megapixel rear camera. On top of that, it sports an incredible thin bezel. As of right now, it’ll only be available in Japan this December, but depending on how it sells, it’s possible we could see it in other markets.